Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-11 IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) 4 Berman David M S - Sale D 36.28 -19,081
2025-09-11 CGON / CG Oncology, Inc. 4 Liu Brian Guan-Chyun By Seven Fleet Partners LP P - Purchase I 33 1,515,151
2025-09-11 IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) 4 Berman David M M - Exercise D 17.46 19,081
2025-09-11 AVXL / Anavex Life Sciences Corp. 4 MISSLING CHRISTOPHER U M - Exercise D 5.04 187,500
2025-09-11 AVXL / Anavex Life Sciences Corp. 4 MISSLING CHRISTOPHER U F - Taxes D 9.58 -145,048
2025-09-10 TIL / Instil Bio, Inc. 4 Laumas Sandeep S - Sale D 23.04 -17,539
2025-09-10 IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) 4 Berman David M S - Sale D 36.77 -1,200
2025-09-10 TIL / Instil Bio, Inc. 4 Laumas Sandeep S - Sale D 23.88 -12,461
2025-09-10 IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) 4 Berman David M S - Sale D 36.12 -30,138
2025-09-10 RGNX / REGENXBIO Inc. 4 Simpson Curran S - Sale D 10.02 -7,734
2025-09-10 TSHA / Taysha Gene Therapies, Inc. 4 Nagendran Sukumar S - Sale D 3.23 -200,000
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 119.64 -3,262
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 122.23 -2,179
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 121.42 -7,584
2025-09-10 HALO / Halozyme Therapeutics, Inc. 4 LaBrosse Nicole S - Sale D 75.929 -13,240
2025-09-10 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher S - Sale D 4.71 -100,000
2025-09-10 HALO / Halozyme Therapeutics, Inc. 4 LaBrosse Nicole S - Sale D 75.291 -6,760
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 120.19 -14,882
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 118.32 -1,108
2025-09-10 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.8151 -350,000
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony S - Sale D 116.34 -96
2025-09-10 ELUT / Elutia Inc. 4 Mills C Randal M - Exercise D 27,083
2025-09-10 TIL / Instil Bio, Inc. 4 Laumas Sandeep M - Exercise D 12.68 13,000
2025-09-10 IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) 4 Berman David M M - Exercise D 17.46 31,338
2025-09-10 GILD / Gilead Sciences, Inc. 4 Mercier Johanna M - Exercise D 3,844
2025-09-10 TSHA / Taysha Gene Therapies, Inc. 4 Nagendran Sukumar M - Exercise D 0.6989 41,150
2025-09-10 GILD / Gilead Sciences, Inc. 4 Telman Deborah H M - Exercise D 1,315
2025-09-10 GILD / Gilead Sciences, Inc. 4 O'Day Daniel Patrick M - Exercise D 10,427
2025-09-10 GILD / Gilead Sciences, Inc. 4 Dickinson Andrew D M - Exercise D 3,696
2025-09-10 TIL / Instil Bio, Inc. 4 Laumas Sandeep M - Exercise D 11.60 17,000
2025-09-10 ELUT / Elutia Inc. 4 Williams Michelle LeRoux M - Exercise D 12,500
2025-09-10 ELUT / Elutia Inc. 4 Ferguson Matthew M - Exercise D 29,000
2025-09-10 HALO / Halozyme Therapeutics, Inc. 4 LaBrosse Nicole M - Exercise D 12.07 11,271
2025-09-10 GILD / Gilead Sciences, Inc. 4 Wilfong Diane E. M - Exercise D 921
2025-09-10 RGEN / Repligen Corporation 4 Hunt Anthony M - Exercise D 33.87 20,000
2025-09-10 HALO / Halozyme Therapeutics, Inc. 4 LaBrosse Nicole M - Exercise D 12.49 1,135
2025-09-10 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher G - Gift D -20,000
2025-09-10 GILD / Gilead Sciences, Inc. 4 Wilfong Diane E. F - Taxes D 115.25 -338
2025-09-10 ELUT / Elutia Inc. 4 Ferguson Matthew F - Taxes D 1.36 -10,348
2025-09-10 ELUT / Elutia Inc. 4 Williams Michelle LeRoux F - Taxes D 1.36 -3,950
2025-09-10 GILD / Gilead Sciences, Inc. 4 O'Day Daniel Patrick F - Taxes D 115.25 -4,949
2025-09-10 GILD / Gilead Sciences, Inc. 4 Dickinson Andrew D F - Taxes D 115.25 -1,751
2025-09-10 GILD / Gilead Sciences, Inc. 4 Telman Deborah H F - Taxes D 115.25 -634
2025-09-10 GILD / Gilead Sciences, Inc. 4 Mercier Johanna F - Taxes D 115.25 -1,819
2025-09-10 ELUT / Elutia Inc. 4 Mills C Randal F - Taxes D 1.36 -9,664
2025-09-10 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher C - Conversion D 120,000
2025-09-09 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 2.0004 -449,226
2025-09-09 INKT / MiNK Therapeutics, Inc. 4 Buell Jennifer A - Award D 15.36 18,229
2025-09-08 IPSC / Century Therapeutics, Inc. 4 Carr Douglas S - Sale D 0.500 -263
2025-09-08 TWST / Twist Bioscience Corporation 4 Cho Dennis S - Sale D 25.76 -269
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)